NYSCF Scientists Accelerate Multiple Sclerosis Research With New Protocol

NYSCF Principal Investigator Dr. Valentina Fossati and NYSCF – Druckenmiller Postdoctoral Fellow Dr. Panagiotis Douvaras improved a method of deriving oligodendrocyte progenitor cells – the types of brain cells implicated in multiple sclerosis and other disorders – from induced pluripotent stem (iPS) cells in only 55 days. This breakthrough, published in Nature Protocols, describes a robust, reproducible protocol that is significantly faster than previous techniques, enabling researchers to accelerate and complete experiments that have not been possible before. This technique will vastly improve research on multiple sclerosis and other neurological disorders as well as accelerate drug testing and new treatment discovery.

Read the paper in Nature Protocols

Diseases & Conditions:

Multiple Sclerosis

People mentioned: